Disseminated primary varicella after initiation of infliximab for Crohn's disease [5]

American Journal of Gastroenterology

Volumn 99, Issue 12, 2004, Pages 2503-2504

  Leung, Verna S ^a,c   Nguyen, Michelle T ^a,b   Bush, Thomas M ^a  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c Dept of Internal Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; CORTICOSTEROID; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE;

ABDOMINAL ABSCESS; ADULT; AUTOPSY; CASE REPORT; CHICKENPOX; CROHN DISEASE; DEATH; DIAGNOSTIC PROCEDURE; DISSEMINATED INTRAVASCULAR CLOTTING; HISTOPLASMOSIS; HUMAN; INFECTION SENSITIVITY; LETTER; LISTERIOSIS; LIVER FAILURE; MALE; MILIARY TUBERCULOSIS; MYCOSIS; NONHUMAN; PNEUMOCYSTOSIS; PNEUMONIA; PRIORITY JOURNAL; RASH; SEPSIS; VARICELLA ZOSTER VIRUS;

ADULT; ANTIBODIES, MONOCLONAL; CHICKENPOX; CROHN DISEASE; FATAL OUTCOME; GASTROINTESTINAL AGENTS; HUMANS; MALE;

EID: 11144316621     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.41389_7.x     Document Type: Letter

References (6)

1. Schaible TF. Important drug warning (letter). Centocor, Inc., October 2001.
2. Colombel J, Loftus EV, Tremaine WJ, et al. The safety profile of infliximab in patients with Crohn's disease: The Mayo clinic experience in 500 patients. Gastroenterology 2004;126(1):19-31.
3. Farrell RJ, Shah SA, Lodhavia PJ. Clinical experience with infliximab therapy in 100 patients with Crohn's disease. Am J Gastroenterol 2000;95(12):3490-7.
4. Ricart E, Panaccione R, Loftus EV, et al. Infliximab for Crohn's disease in clinical practice at the mayo clinic: The first 100 patients. Am J Gastroenterol 2001;96(3):722-9.
5. Maillot C, Riachi G, Francois A. Digestive manifestations in an immunocompetent adult with varicella. Am J Gastroenterol 1997;92(8):1361-3.
6. Dits H, Frans E, Wilmer A, et al. Varicella-zoster virus infection associated with acute liver failure. Clin Infect Dis 1998;27:209-10.